Physician profile
Amber E Schaub
NPI 1235464785
$1,280.08
in general payments reported to CMS, 2019-2025
12 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $552 · 2022: $57.02 · 2023: $278 · 2024: $209 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $601.77 | 2021-2025 | Endurant Iis, Hawkone, Ellipsys Vascular Access System |
| Penumbra, INC. | $226.95 | 2021 | |
| Boston Scientific Corporation | $111.00 | 2025 | Avvigo Guidance System |
| Abbott Laboratories | $105.70 | 2024 | Diamondback Peripheral |
| Shockwave Medical, INC | $57.02 | 2022 | |
| Silk Road Medical, INC. | $50.54 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cordis US Corp. | $28.20 | 2023 | Mynx Control |
| W. L. Gore & Associates, INC. | $24.70 | 2025 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Paratek Pharmaceuticals, INC. | $20.72 | 2024 | Nuzyra |
| Philips North America LLC | $20.72 | 2023 | |
| Veryan Medical Incorporated | $19.67 | 2025 | Biomimics 3d Vascular Stent System |
| Tactile Systems Technology INC | $13.09 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Schaub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.